Skip to content

Centene CNC Other intangible assets—net

Other intangible assets—net at other companies

CVS Health logo
CVS HealthCVS
$25.07B-5.6%
UnitedHealth Group logo
UnitedHealth GroupUNH
$20.09B-12.4%
Elevance Health logo
Elevance HealthELV
$11.09B-7.1%
Cencora logo
CencoraCOR
$6.05B+56.7%
Astrana Health logo
Astrana HealthASTH
$257.12M+130%
Humana logo
HumanaHUM

Other financials

Income statement

See full
Revenue$49.9B+7.1%
Gross profit$49.2B+7.2%
Operating income$1.9B+21.3%
Net income$1.5B+17.5%
EPS (diluted)$3.11+18.3%

Balance sheet

See full
Cash & equivalents$21.3B+43.5%
Total debt$16.4B-10.6%
Total equity$21.4B-23.2%
Total assets$81.2B-6.7%

Cash flow

See full
Operating cash flow$4.4B+189%
CapEx$200.0M+48.1%
Free cash flow$4.2B+203%

Valuation

See full
Market cap$31.7B+25.7%
Enterprise value$26.8B-3.7%
P/S0.2×0.0×

Profitability

See full
Gross margin98.7%+0.3pp
Operating margin-3.7%-5.8pp
Net margin-3.3%-5.3pp
FCF margin3.6%+2.7pp

Returns & leverage

See full
Return on equity-26.1%-38.7pp
Debt / equity0.8×+0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Centene in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: Centene’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Centene's other intangible assets—net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Centene's other intangible assets—net?
Centene (CNC) reported other intangible assets—net of $4.36B in Q1 2026.
How has Centene's other intangible assets—net changed year-over-year?
Centene's other intangible assets—net decreased by 16.7% year-over-year, from $5.24B to $4.36B.
What is the long-term trend for Centene's other intangible assets—net?
Over 5 years (2020 to 2025), Centene's other intangible assets—net has grown at a -11.6% compound annual growth rate (CAGR), from $8.39B to $4.53B.
What does other intangible assets—net mean?
This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.